A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis



Status:Recruiting
Conditions:Psoriasis, Dermatology, Dermatology, Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery
Healthy:No
Age Range:18 - Any
Updated:3/29/2019
Start Date:November 14, 2018
End Date:March 16, 2020
Contact:Novartis Pharmaceuticals
Email:novartis.email@novartis.com
Phone:1-888-669-6682

Use our guide to learn which trials are right for you!

A Randomized, Double-blind, Placebo-controlled Multicenter Dose Ranging Study to Assess the Safety and Efficacy of Multiple Oral ZPL389 Doses in Patients With Moderate to Severe Atopic Dermatitis (ZEST Trial)

The purpose of this study is to assess ZPL389 efficacy and safety in subjects with moderate
to severe atopic dermatitis.


Inclusion Criteria:

- Subjects must give a written, signed and dated informed consent

- Chronic atopic dermatitis present for at least 1 year before Baseline

- Moderate to severe atopic dermatitis defined as per EASI, IGA and BSA.

- Documented recent history (within 6 months before the screening visit) of inadequate
response to treatment with topical medications or for whom topical treatments are
otherwise medically inadvisable

- Candidate for systemic treatment

Exclusion Criteria:

- Any skin disease that would confound the diagnosis or evaluation of atopic dermatitis
disease activity

- Use of other investigational drugs within 5 half-lives of enrollment, or within 30
days or until the expected pharmacodynamic effect has returned to baseline, whichever
is longer.

- History of hypersensitivity to any of the study drug constituents or to drugs of
similar chemical classes.

- Participation in prior ZPL389 studies
We found this trial at
19
sites
Saint Louis, Missouri 63128
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Birmingham, Alabama 35209
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Centennial, Colorado 80112
?
mi
from
Centennial, CO
Click here to add this to my saved trials
Fairborn, Ohio 45324
?
mi
from
Fairborn, OH
Click here to add this to my saved trials
Greer, South Carolina 29651
?
mi
from
Greer, SC
Click here to add this to my saved trials
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials
Louisville, Kentucky 40202
?
mi
from
Louisville, KY
Click here to add this to my saved trials
Norfolk, Virginia 23507
?
mi
from
Norfolk, VA
Click here to add this to my saved trials
Omaha, Nebraska 68144
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Oregon City, Oregon 97045
?
mi
from
Oregon City, OR
Click here to add this to my saved trials
Owensboro, Kentucky 42301
?
mi
from
Owensboro, KY
Click here to add this to my saved trials
Pembroke Pines, Florida 33024
?
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Pflugerville, Texas 78660
?
mi
from
Pflugerville, TX
Click here to add this to my saved trials
San Antonio, Texas 78207
Novartis Novartis, which was created in 1996 by the merger of the Swiss companies Ciba-Geigy...
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
San Diego, California 92123
?
mi
from
San Diego, CA
Click here to add this to my saved trials
Tampa, Florida 33613
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Verona, New Jersey 07044
?
mi
from
Verona, NJ
Click here to add this to my saved trials
Waterloo, Ontario
?
mi
from
Waterloo,
Click here to add this to my saved trials
West Jordan, Utah 84088
?
mi
from
West Jordan, UT
Click here to add this to my saved trials